webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

BCN-PEG4-OH

  CAS No.:   Cat No.: BADC-01229   Purity: ≥95% 4.5  

BCN-PEG4-OH is a hydroxyl-terminated ADC linker featuring BCN for fast, copper-free click chemistry, improving hydrophilicity and stability in antibody-drug conjugate design.

BCN-PEG4-OH

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H31NO6
Molecular Weight
369.45
Shipping
Room temperature
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
-20°C

BCN-PEG4-OH, a versatile bifunctional linker, finds diverse applications in bioconjugation. Here are four key applications of BCN-PEG4-OH, presented with high perplexity and burstiness:

Bioorthogonal Chemistry: Serving as a pivotal tool in bioorthogonal labeling, BCN-PEG4-OH enables precise and selective chemical modifications within biological systems. The strain-promoted azide-alkyne cycloaddition (SPAAC) reaction facilitates swift and biocompatible labeling of biomolecules. This method empowers the exploration of dynamic biological processes in live cells and organisms, all while preserving the integrity of native biochemical pathways.

Drug Delivery Systems: BCN-PEG4-OH plays a crucial role in conjugating therapeutic agents to targeting ligands, thereby enhancing the specificity and efficacy of drug delivery. The incorporation of a PEG4 spacer imparts solubility and diminishes immunogenicity, thereby enhancing the pharmacokinetic properties of the conjugates. This application holds immense promise for developing targeted therapies that promise enhanced effectiveness with minimized side effects.

Protein/Peptide Conjugation: Enabling precise site-specific conjugation of proteins and peptides, BCN-PEG4-OH fuels a myriad of research and therapeutic endeavors. By linking therapeutic peptides to carrier proteins or other molecules, this linker boosts stability and bioactivity, paving the way for novel biologics and vaccine candidates designed with heightened efficacy and potency.

Diagnostic Imaging: BCN-PEG4-OH emerges as a potent tool for crafting imaging probes tailored for diagnostic applications. By conjugating imaging agents like fluorophores or radionuclides with biomolecules, it enables targeted imaging of specific tissues or cellular components. This technology proves instrumental in early disease detection and monitoring, particularly for conditions like cancer and inflammatory ailments.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-Val-Ala-PAB-PNP | BCN-PEG1-Val-Cit-OH | Aminooxy-PEG2-BCN | Biotin-PEG2-acid | Fmoc-Gly-Gly-Phe-OH | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | CL2A-SN-38 DCA | Boc-Ser(O-propargyl)-OH (DCHA) | m-PEG3-NHS ester | AcS-PEG8-NHS | BCN-PEG4-OH
Send Inquiry
Verification code
Inquiry Basket